Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 5.6 EX-5.6
- 5.7 EX-5.7
- 5.8 EX-5.8
- 5.9 EX-5.9
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
RMD Networks similar filings
- 8 Apr 13 Registration of securities issued in business combination transactions
- 26 Nov 10 Registration of securities issued in business combination transactions
- 19 Apr 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated May 19, 2009, with respect to the combined statements of assets acquired and liabilities assumed of the Second Territory Business of ACON Laboratories, Inc., AZURE Institute, Inc., Oakville Hong Kong Co., Ltd, and ACON Biotech (Hangzhou) Co., Ltd as of December 31, 2008 and 2007, and the related statements of revenue and direct expenses for each of the years ending December 31 2008 and 2007, appearing in the Form 8-K of Inverness Medical Innovations, Inc. filed on July 1, 2009, which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference in the Registration Statement of the aforementioned report and to the use of our name as it appears under the caption “Experts.”
/s/ Grant Thornton Zhonghua
Shanghai, China
April 16, 2010
April 16, 2010